Bennie H. Jeng, MD
PHILADELPHIA – Cornea expert Bennie H. Jeng, MD, has been named chair of the Department of Ophthalmology and director of the Scheie Eye Institute at Penn Medicine. Jeng, who is currently a professor and chair of the Department of Ophthalmology and Visual Sciences at the University of Maryland School of Medicine, will assume his new role at Penn in July 2022.
“Dr. Jeng has been a transformative leader, clinician, researcher, and educator, with a proven track record of advancing medical education, global health, and translational research, and we are proud to welcome him to Penn,” said J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System.
Jeng is a nationally recognized clinician-scientist specializing in cornea and external eye diseases and an alumnus of the Perelman School of Medicine. He began his academic career at the Cleveland Clinic in 2006 before transitioning to the University of California San Francisco (UCSF), where he rose through the academic ranks, serving as co-director of the UCSF cornea service, director of the Proctor/UCSF Cornea Fellowship program, and as Chief of Ophthalmology at the San Francisco General Hospital. Jeng was recruited to the University of Maryland in 2013, where under his leadership, the Department of Ophthalmology expanded its clinical service from three to 12 sites, grew its research faculty, increased the number of endowments, and recreated its residency program.
Jeng has had a broad institutional as well as global impact. At Maryland, he served as founding medical director of the Multispecialty Ambulatory Surgical Center as well as co-chair of the School of Medicine’s Promotions Reform Committee, and he was actively involved in medical education. Jeng is also a regular surgical instructor overseas, having taught corneal transplantation in numerous countries, including India, China, and Kuwait. During the COVID-19 pandemic, he has been providing international surgical instruction virtually.
After earning a bachelor’s degree from Washington University, Jeng graduated from the Perelman School of School of Medicine in 1998. He completed his ophthalmology residency at the Cole Eye Institute of the Cleveland Clinic, followed by a fellowship at UCSF. He also holds a master’s degree in Clinical Investigation. Jeng has held leadership posts in many ophthalmologic societies, including serving as president of the Cornea Society, president of the Eye and Contact Lens Association, and on the Board of Directors of the American Board of Ophthalmology.
“Dr. Jeng’s impressive biomedical research background, paired with his commitment to teaching and excellence in clinical care, will make him a tremendous asset to Penn’s Scheie Eye Institute and the Department of Ophthalmology, which is among the very best in the country, providing life-changing, transformative care to patients through an array of leading approaches,” said Kevin B. Mahoney, CEO of the University of Pennsylvania Health System.
Jeng succeeds Joan O’Brien, MD, who served as chair for 12 years. She will assume a new role as the inaugural director of the Penn Medicine Center for Ophthalmic Genetics in Complex Diseases.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.